コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s the major protein component of the forming enamel matrix.
2 ses) and to the newly secreted extracellular enamel matrix.
3 ndary revealed the "fish net" pattern of the enamel matrix.
4 se in EMSP1 activity in the transition-stage enamel matrix.
5 proteins constituting most of the developing enamel matrix.
6 est amounts of ameloblastin were detected in enamel matrix.
7 hanges in the constituents of the developing enamel matrix.
8 hers on similar structures in the developing enamel matrix.
9 ntrolled changes to the pH of the developing enamel matrix.
10 sported from ameloblasts into the developing enamel matrix.
11 this is also when MMP20 is secreted into the enamel matrix.
12 y disrupting normal protein removal from the enamel matrix.
13 results in acidification of the mineralizing enamel matrix.
14 ns as the structural scaffolds in developing enamel matrix.
15 ay serve several functional roles within the enamel matrix.
16 nsists of the amelogenin fraction of porcine enamel matrix (AMEL) suspended in a vehicle of propylene
18 the proteinase from porcine transition-stage enamel matrix and characterized it by partial protein se
19 ss amelogenin properly, possesses an altered enamel matrix and rod pattern, has hypoplastic enamel th
20 le proteinases are present in the developing enamel matrix, and the precise role of enamelysin in the
21 transcripts containing exon4 (AMG+4) in the enamel matrix, and the relative binding of recombinant A
23 ese findings constrain the emerging model of enamel matrix assembly by helping to define the limits o
25 racterised by near-normal volumes of organic enamel matrix but with weak, creamy-brown opaque enamel
26 aturation, and proteolytic processing of the enamel matrix by KLK4 is critical for proper enamel form
27 ion results in a release of protons into the enamel matrix, causing an acidification of the local mic
28 ally substitute for C/EBPalpha to produce an enamel matrix competent to direct biomineralization.
30 olars revealed reductions in early expressed enamel matrix components (Odontogenic ameloblast-associa
31 t requires a combined interaction with other enamel matrix components of EMD to direct the regenerati
32 ible for the transportation and secretion of enamel matrix components, and proteases processing ename
33 x serine proteinase 1, an enzyme involved in enamel matrix degradation and with a putative role in th
35 d bone allograft (DFDBA) in combination with enamel matrix derivative (EMD + DFDBA) compared to ename
36 rafts (ADMG) + CAF and SCTG + CAF or between enamel matrix derivative (EMD) + CAF and SCTG + CAF.
37 clinical trial was that local application of enamel matrix derivative (EMD) added to papilla reflecti
38 matrix derivative (EMD + DFDBA) compared to enamel matrix derivative (EMD) alone in the treatment of
43 periodontal surgery using the combination of enamel matrix derivative (EMD) and natural bone mineral
44 ly autogenous blood-dervied products (ABPs), enamel matrix derivative (EMD) and recombinant human pla
49 In this study, we compare the effects of enamel matrix derivative (EMD) associated with a hydroxy
50 this study, we compare the effectiveness of enamel matrix derivative (EMD) associated with a simplif
51 sidering xenogeneic collagen matrix (CM) and enamel matrix derivative (EMD) characteristics, it is su
52 s study was to evaluate the effectiveness of enamel matrix derivative (EMD) combined with a bovine-de
53 ctice reports on the clinical efficacy of an enamel matrix derivative (EMD) combined with either demi
56 ally, the use of collagen matrix (CM) and/or enamel matrix derivative (EMD) for the treatment of dehi
72 ized freeze-dried bone allograft (DFDBA) and enamel matrix derivative (EMD) have been used with varyi
73 ith a xenogenous collagen matrix (CM) and/or enamel matrix derivative (EMD) in combination with a cor
75 nnective tissue graft (CTG) with and without enamel matrix derivative (EMD) in the treatment of multi
76 he large body of evidence on the efficacy of enamel matrix derivative (EMD) in the treatment of perio
77 he large body of evidence on the efficacy of enamel matrix derivative (EMD) in the treatment of perio
82 this study was to determine the effect of an enamel matrix derivative (EMD) on cementoblast behavior
83 cemento-inductivity effect of calcitriol and enamel matrix derivative (EMD) on human periodontal liga
84 of this study is to determine the impact of enamel matrix derivative (EMD) on superoxide (O(2)(-)) g
85 ellular dermal matrix (ADM) with and without enamel matrix derivative (EMD) on the percentage of root
86 radiographic and patient-centered results of enamel matrix derivative (EMD) therapy in intrabony defe
87 have been demonstrated with the addition of enamel matrix derivative (EMD) to demineralized freeze-d
91 neutral ethylene diamine tetracetic acid and enamel matrix derivative (EMD) were first used to treat
93 modality as compared with the association of enamel matrix derivative (EMD) with ABG in the managemen
94 milarly, in guided tissue regeneration (GTR)/enamel matrix derivative (EMD) with and without laser tr
95 inical studies suggest that a combination of enamel matrix derivative (EMD) with demineralized freeze
96 have also demonstrated the efficacy of using enamel matrix derivative (EMD) with demineralized freeze
97 of periodontal regeneration treatments with enamel matrix derivative (EMD), a commercial formulation
98 ontaining different concentrations of either enamel matrix derivative (EMD), amelogenin, platelet-der
99 of autologous blood-derived products (ABPs), enamel matrix derivative (EMD), recombinant human platel
100 of autologous blood-derived products (ABPs), enamel matrix derivative (EMD), recombinant human platel
101 m of this study is to evaluate the effect of enamel matrix derivative (EMD), tyrosine-rich amelogenin
108 logenin fraction of porcine enamel matrix in enamel matrix derivative (i.e., AMEL) is not antibacteri
109 enic (bone morphogenetic protein [BMP]-2 and enamel matrix derivative [EMD]) were compared to a contr
112 xenograft used alone and in combination with enamel matrix derivative are effective for the treatment
113 h >/= 4 mm) was treated regeneratively using enamel matrix derivative at two centers (Frankfurt am Ma
114 from the same surgical site was treated with enamel matrix derivative in a dampen dish and then added
115 n enhancement of hard tissue parameters when enamel matrix derivative is added to demineralized freez
116 ort the concept that clinical application of enamel matrix derivative may enhance periodontal wound r
117 Adjunctive autologous bone grafting with enamel matrix derivative might be significantly benefici
118 tudy was to compare the clinical efficacy of enamel matrix derivative placed under a coronally advanc
120 cept for MRC at the 12-month follow-up where enamel matrix derivative plus CAF exhibited superior res
121 ve tissue grafts (SCTGs), matrix grafts, and enamel matrix derivative protein (EMD) procedures were s
122 A recent study suggests that the addition of enamel matrix derivative to demineralized freeze-dried b
123 he results of this study, the application of enamel matrix derivative to denuded root surfaces receiv
124 of a commercially prepared embryonic porcine enamel matrix derivative to induce new bone formation in
127 se histologic sections strongly suggest that enamel matrix derivative works in a biomimetic fashion b
128 h a bone replacement graft [combination], or enamel matrix derivative), according to predefined crite
129 rformed utilizing water-jet decontamination, enamel matrix derivative, and locally harvested autogeno
130 utilizing collagen membrane, with or without enamel matrix derivative, can be successfully used in ob
131 ed flap plus acellular dermal matrix grafts, enamel matrix derivative, or collagen matrix led to the
132 ogics in root coverage procedures, including enamel matrix derivative, platelet-derived growth factor
134 ly autologous blood-derived products (ABPs), enamel matrix derivatives (EMD) and recombinant human pl
138 cle cells and to determine the effects of an enamel matrix-derived protein (EMD) on these cells.
140 f ameloblastin in the ameloblasts and in the enamel matrix during different postnatal (PN) days (days
142 enting unwanted mineral formation within the enamel matrix during the secretory stage of amelogenesis
143 in parallel to their role in the developing enamel matrix, ERPs have retained an evolutionary conser
148 8.9 +/- 11.5); and the 10 sites treated with enamel matrix gained on average 5.9 +/- 1.5 mm of CAL (C
149 asts secrete amelogenins on the pre-existing enamel matrix glycoproteins at the dentine-enamel juncti
150 ypothesis that amelogenins may interact with enamel matrix glycoproteins is tested by hemagglutinatio
154 -length amelogenin protein in the developing enamel matrix, loss of ameloblast phenotype, increased a
160 hesize that abnormal extracellular pH in the enamel matrix of mice with the cystic fibrosis gene knoc
163 idification while still leading to defective enamel matrix pH extracellularly. We identify a vesicle
166 The correct spatiotemporal patterning of enamel matrix protein (EMP) expression is fundamental to
167 meloblastin (AMBN), the second most abundant enamel matrix protein (EMP), plays a critical role in am
168 nin (AMELX) is the predominant extracellular enamel matrix protein and plays an essential role in ena
170 eatment of intrabony defects treated with an enamel matrix protein derivative (EMD) combined with eit
172 ine bone mineral (DBBM) combined with either enamel matrix protein derivative (EMD) or collagen membr
174 loblastin (AMBN) is the second most abundant enamel matrix protein expressed during amelogenesis.
177 mm defects, the height of new cementum with enamel matrix protein treatment was 45% greater than the
179 Mutations in ENAM, which encodes the largest enamel matrix protein, enamelin, have been demonstrated
182 assembly by helping to define the limits of enamel matrix protein-protein interactions that are beli
183 , new tissue height was more similar between enamel matrix protein-treated defects and control defect
186 Intrabony defects were treated either with enamel matrix proteins (EMP group) or with enamel matrix
188 aluate the effectiveness of a combination of enamel matrix proteins (EMP), bovine porous bone mineral
189 -X-Y motif, the molecular mechanism by which enamel matrix proteins (EMPs) assemble into the organic
190 ntal defects can be achieved with the use of enamel matrix proteins (EMPs) or by grafting with bovine
193 ate, gene expression profiles of major tooth enamel matrix proteins (EMPs), amelogenin (AMELX), ename
194 have identified evidence that the genes for enamel matrix proteins (EMPs), milk caseins, and salivar
196 ve analysis may suggest a positive effect of enamel matrix proteins and a negative effect of DG used
197 ns constitute the major portion of secretory enamel matrix proteins and are known to be highly altern
199 tive (EMD) contains a variety of hydrophobic enamel matrix proteins and is extracted from developing
200 Differentiated ameloblasts synthesizing enamel matrix proteins and odontoblasts expressed the ge
201 ects, one using extracellular matrix such as enamel matrix proteins and the other using growth factor
202 i.e., self-assembly, associations with other enamel matrix proteins and with calcium phosphate biomin
205 enamel probably by processing and regulating enamel matrix proteins around mineralization front appar
206 , we found that proteolysis of extracellular enamel matrix proteins by MMP20 is not required for the
207 h enamel matrix proteins (EMP group) or with enamel matrix proteins combined with bovine porous bone
211 t data that support cooperative functions of enamel matrix proteins in mediating the structural hiera
212 Several studies have examined the role of enamel matrix proteins in root formation and periodontal
213 arding the potential role of the assembly of enamel matrix proteins in the regulation of crystal grow
216 work is needed to further incorporate other enamel matrix proteins into the system, this study bring
218 d this technique to determine the effects of enamel matrix proteins on the gene activities of periodo
219 fect of DG used alone or in combination with enamel matrix proteins on the regeneration of Class III
220 nt of various sized periodontal defects with enamel matrix proteins stimulated substantial periodonta
221 to investigate the adsorption properties of enamel matrix proteins to bone grafts after surface coat
224 the surface of bone grafting materials when enamel matrix proteins were delivered in either a liquid
225 neutral ethylene diamine tetracetic acid and enamel matrix proteins were used to treat the defects.
226 Amelogenins are a group of extracellular enamel matrix proteins which are believed to be involved
229 eviously reported that genes for three major enamel matrix proteins, five proteins necessary for dent
230 ghly conserved AH motif is absent from other enamel matrix proteins, including amelogenin, enamelin,
231 est that in addition to its role of cleaving enamel matrix proteins, MMP20 also cleaves junctional co
232 ta (AI) can be caused by the deficiencies of enamel matrix proteins, molecules responsible for the tr
233 rmal cells that express transcripts encoding enamel matrix proteins, suggest hormonal control of epit
244 ine proteases, has been variously designated enamel matrix serine proteinase 1 (EMSP1), prostase, KLK
246 igen (PSA) and 78% identity with the porcine enamel matrix serine proteinase 1, an enzyme involved in
247 s intracellularly and is not secreted to the enamel matrix space to regulate mineralization, and is f
248 he removal of proteins from the mineralizing enamel matrix to allow for crystallite growth until full
251 ion of proteins secreted into the developing enamel matrix, we have constructed a porcine enamel orga
252 the most superficial layer of the developing enamel matrix, while other enamelin cleavage products ar